PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
58 hedge funds and large institutions have $53M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 3 closing their positions.
Holders
58
Holders Change
+8
Holders Change %
+16%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
17
Reduced
16
Closed
3
Calls
$239K
Puts
$1K
Net Calls
+$238K
Net Calls Change
+$177K
